Appili Therapeutics Inc., the Halifax company dedicated to fighting infectious diseases, has named Yoav Golan, who’s been an advisor to Appili since the company’s inception, as its first Chief Medical Officer.
In a statement, Armand Balboni, company CEO, said that Golan brings over 25 years of infectious disease expertise to the role. He’s recently served as an attending physician in the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center in Boston and has also been an associate professor at Tufts University School of Medicine.
The company, which has listed on